These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33259835)

  • 1. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Koutoukidis DA; Koshiaris C; Henry JA; Noreik M; Morris E; Manoharan I; Tudor K; Bodenham E; Dunnigan A; Jebb SA; Aveyard P
    Metabolism; 2021 Feb; 115():154455. PubMed ID: 33259835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Koutoukidis DA; Astbury NM; Tudor KE; Morris E; Henry JA; Noreik M; Jebb SA; Aveyard P
    JAMA Intern Med; 2019 Sep; 179(9):1262-1271. PubMed ID: 31260026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
    Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
    Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
    Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
    Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
    Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels.
    Salman AA; Sultan AAEA; Abdallah A; Abdelsalam A; Mikhail HMS; Tourky M; Omar MG; Youssef A; Ahmed RA; Elkassar H; Seif El Nasr SM; Shaaban HE; Atallah M; GabAllah GMK; Salman MA
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1769-1773. PubMed ID: 32153044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.
    Popov VB; Thompson CC; Kumar N; Ciarleglio MM; Deng Y; Laine L
    Dig Dis Sci; 2016 Sep; 61(9):2477-87. PubMed ID: 27207181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
    Guo XF; Yang B; Tang J; Li D
    Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.
    Bower G; Toma T; Harling L; Jiao LR; Efthimiou E; Darzi A; Athanasiou T; Ashrafian H
    Obes Surg; 2015 Dec; 25(12):2280-9. PubMed ID: 25917981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
    Westfall E; Jeske R; Bader AR
    Am Fam Physician; 2020 Nov; 102(10):603-612. PubMed ID: 33179890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB; Bhathal PS; O'Brien PE
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.